Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors Read more about Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors
Table 14. Antiretroviral Drug Use in Pregnant People With HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | Overview Read more about Table 14. Antiretroviral Drug Use in Pregnant People With HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | Overview
Antiretroviral Drug Resistance and Resistance Testing in Pregnancy Read more about Antiretroviral Drug Resistance and Resistance Testing in Pregnancy
Initial Evaluation and Continued Monitoring of HIV-Related Assessments During Pregnancy Read more about Initial Evaluation and Continued Monitoring of HIV-Related Assessments During Pregnancy
Table 7. Summary of Pre-Clinical and Human Data on, and Indications for, Opportunistic Infection Drugs During Pregnancy Read more about Table 7. Summary of Pre-Clinical and Human Data on, and Indications for, Opportunistic Infection Drugs During Pregnancy
Table 6. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections That Require Dosage Adjustment in Patients with Renal Insufficiency Read more about Table 6. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections That Require Dosage Adjustment in Patients with Renal Insufficiency
